logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jørn Herrstedt

Zealand University Hospital

51H指数
278论文数
1.5W被引数
收录论文 68
发表时间
logo
Defining and addressing loneliness in older adults with cancer: an international Delphi consensus from the Multinational Association of Supportive Care in Cancer Geriatrics Study Group定义并应对癌症老年患者的孤独感：来自多国癌症支持治疗协会姑息治疗组国际Delphi共识
errThe Lancet Healthy Longevity
IF0
err2026-01-07
err0
errOAAI
errEnrique Soto-Perez-de-Celis; Kristen R Haase; Sriram Yennu; Etienne Brain; Chad Yixian Han; Jørn Herrstedt; Ayumu Matsuoka; Joana Marinho; Lewis Mustian; Sophie Pilleron; Imogen Ramsey; Christopher Steer; Matti Aapro
err分享
err收藏
Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study奈妥匹坦/帕洛诺司琼联合地塞米松每周给药在5周同步放化疗期间的安全性及止吐疗效——DANGER-EMESIS研究
errSUPPORTIVE CARE IN CANCER
IF3
err2025-05-28
err0
errOAAI
errDetlefsen, Sofie S.; Andersen, Ditte S.; Knudsen, Anja O.; Nottrup, Trine J.; Moller, Soren; Nyvang, Gitte-Bettina; Jorgensen, Trine L.; Herrstedt, Jorn; Ruhlmann, Christina H.
err分享
err收藏
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel质量调整的无疾病进展症状或治疗毒性的时间，在原发性晚期或复发性子宫内膜癌患者中使用dostarlimab联合卡铂-紫杉醇治疗与卡铂-紫杉醇治疗相比
errInternational Journal of Gynecological Cancer
IF4.7
err2025-05-21
err0
errOAAI
errDana M. Chase; Jørn Herrstedt; Eirwen M. Miller; Lucy Gilbert; Oleksandr Zub; Cara Mathews; Roberto Angioli; Michael Teneriello; Martina Gropp-Meier; Matthew A. Powell; Anna K.L. Reyners; Noelle G. Cloven; Gemma Eminowicz; Sarah E. Gill; Beata Maćkowiak-Matejczyk; Bhavana Pothuri; Vanessa Samouëlian; Angela Jain; Jonathan Boone; Sara Bouberhan; Mansoor Raza Mirza
err分享
err收藏
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safetyENGOT-OV16/NOVA试验中 niraparib 治疗复发卵巢癌的生存率与长期安全性
errgynecologic oncology
IF4.1
err2025-04-01
err0
PREAI
errMatulonis, Ursula A.; Herrstedt, Jorn; Oza, Amit; Mahner, Sven; Redondo, Andres; Berton, Dominique; Berek, Jonathan S.; Haslund, Charlotte A.; Marme, Frederik; Gonzalez-Martin, Antonio; Becourt, Stephanie; Tinker, Anna, V; Ledermann, Jonathan A.; Benigno, Benedict; Lindahl, Gabriel; Colombo, Nicoletta; Malinowska, Izabela A.; Liu, Wenlei; Bains, Manjinder; Monk, Bradley J.; Mirza, Mansoor R.
err分享
err收藏
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)多塔利单抗联合化疗在dMMR/MSI-H原发性晚期或复发性子宫内膜癌患者中的有效性和安全性：一项III期、随机、安慰剂对照试验（ENGOT-EN6-NSGO/GOG-3031/RUBY）。
errgynecologic oncology
IF4.1
err2025-01-01
err4
PREAI
errPowell, Matthew A.; Cibula, David; O'Malley, David M.; Boere, Ingrid; Shahin, Mark S.; Savarese, Antonella; Chase, Dana M.; Gilbert, Lucy; Black, Destin; Herrstedt, Jorn; Sharma, Sudarshan; Kommoss, Stefan; Gold, Michael A.; Thijs, Anna M.; Ring, Kari; Bolling, Magnus Frodin; Buscema, Joseph; Gill, Sarah E.; Nowicki, Paul; Nevadunsky, Nicole; Callahan, Michael; Willmott, Lyndsay; McCourt, Carolyn; Billingsley, Caroline; Ghamande, Sharad A.; He, Zangdong; Balas, Morad Marco; Stevens, Shadi; Fleming, Evelyn; Mirza, Mansoor Raza
err分享
err收藏
Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting
errEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
IF3.4
err2024-06-25
err1
PREAI
errOrhan, Adile; Nguyen, Carolyn; Chan, Alexandre; Herrstedt, Jrn
err分享
err收藏
Impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer: A multicenter randomized clinical trial protocol (FRAGINOC)老年上皮性卵巢癌患者虚弱筛查和老年评估和干预的影响: 一项多中心随机临床试验方案 (FRAGINOC)
errJOURNAL OF GERIATRIC ONCOLOGY
IF2.7
err2024-04-01
err2
PREAI
errCobian, Cristina Daviu; Oreskov, Jakob O.; Blaakaer, Jan; Jespersen, Eva; Jorgensen, Trine L.; Ryg, Jesper; Herrstedt, Jorn; Hogdall, Claus; Lund, Cecilia M.; Seibaek, Lene; Vinther, Anders; Ekmann-Gade, Anne Weng; Schnack, Tine H.
err分享
err收藏
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer卡铂加紫杉醇联合组蛋白去乙酰化抑制剂伏立诺他治疗复发性铂类敏感卵巢癌
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2024-02-03
err4
errOAAI
errMeteran, Hanieh; Knudsen, Anja Or; Jorgensen, Trine Lembrecht; Nielsen, Dorte; Herrstedt, Jorn
err分享
err收藏
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
errESMO OPEN
IF8.3
err2024-02-01
err24
errOAAI
errHerrstedt, J.; Clark-Snow, R.; Ruhlmann, C. H.; Molassiotis, A.; Olver, I.; Rapoport, B. L.; Aapro, M.; Dennis, K.; Hesketh, P. J.; Navari, R. M.; Schwartzberg, L.; Affronti, M. L.; Garcia-Del-Barrio, M. A.; Chan, A.; Celio, L.; Chow, R.; Fleury, M.; Gralla, R. J.; Giusti, R.; Jahn, F.; Iihara, H.; Maranzano, E.; Radhakrishnan, V.; Saito, M.; Sayegh, P.; Bosnjak, S.; Zhang, L.; Lee, J.; Ostwal, V.; Smit, T.; Zilic, A.; Jordan, K.; Scotte, F.
err分享
err收藏
Dostarlimab plus chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC): Analysis of progression free survival (PFS) and overall survival (OS) outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err14
PREAI
errMirza, M. R.; Sharma, S.; Herrstedt, J.; Shahin, M. S.; Cibula, D.; Fleming, E.; Raspagliesi, F.; Buscema, J.; Hanker, L. C.; Coleman, R. L.; Boere, I. A.; Schneider, K.; Gilbert, L.; Slomovitz, B. M.; Teneriello, M. G.; Powell, M. A.; Ghosh, S.; Stevens, S.; Ring, K.; Stuckey, A.
err分享
err收藏
Oral cannabidiol for prevention of chemotherapy-induced peripheral neuropathy
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errNielsen, S. W.; Hasselsteen, S. Dyring; Dominiak, H. Sylow; Labudovic, D.; Herrstedt, J.
err分享
err收藏
Prevention of Taste Alterations in Patients with Cancer Receiving Paclitaxel- or Oxaliplatin-Based Chemotherapy-A Pilot Trial of Cannabidiol
errNUTRIENTS
IF5
err2023-07-01
err6
errOAAI
errDominiak, Helena S. H.; Hasselsteen, Simone D.; Nielsen, Sebastian W.; Andersen, Jens Rikardt; Herrstedt, Jorn
err分享
err收藏
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy
errTHROMBOSIS RESEARCH
IF3.4
err2023-01-01
err9
PREAI
errBjornhart, Birgitte; Kristiansen, Charlotte; Asmussen, Jon; Hansen, Karin Holmskov; Wedervang, Kim; Jorgensen, Trine Lembrecht; Herrstedt, Jorn; Schytte, Tine
err分享
err收藏
Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes使用多频振动法和患者报告的结果解决化疗引起的周围神经病变
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2022-03-27
err2
errOAAI
errNielsen, Sebastian W.; Lindberg, Sanne; Ruhlmann, Christina Halgaard Bruvik; Eckhoff, Lise; Herrstedt, Jorn
err分享
err收藏
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes
errDRUGS & AGING
IF3.8
err2021-12-09
err20
errOAAI
errHerrstedt, Jorn; Lindberg, Sanne; Petersen, Peter Clausager
err分享
err收藏
Intracranial response (ICR) following immunotherapy in non-small cell lung cancer (NSCLC) patients with untreated brain metastasis (BM)
errANNALS OF ONCOLOGY
IF65.4
err2021-09-01
err0
errOAAI
errBjoernhart, B.; Hansen, K. H.; Asmussen, J. T.; Jorgensen, T. L.; Herrstedt, J.; Schytte, T.
err分享
err收藏
Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries
errESMO OPEN
IF8.3
err2021-06-01
err16
errOAAI
errMolassiotis, A.; Tyrovolas, S.; Gine-Vazquez, I; Yeo, W.; Aapro, M.; Herrstedt, J.
err分享
err收藏
Impact of comorbidity and venous thromboembolism on outcome in real-life non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibition (ICI)
errANNALS OF ONCOLOGY
IF65.4
err2020-12-01
err0
errOAAI
errBjoernhart, B.; Kristiansen, C.; Hansen, K. H.; Wedervang, K.; Nyhus, C. H.; Jorgensen, T. L.; Herrstedt, J.; Schytte, T.
err分享
err收藏
The influence of polypharmacy on outcome in real life non-small cell lung cancer (NSCLC) patients treated with immunotherapy
errANNALS OF ONCOLOGY
IF65.4
err2020-09-01
err2
errOAAI
errBjoernhart, B.; Hansen, K. H.; Jorgensen, T. L.; Herrstedt, J.; Schytte, T.
err分享
err收藏
The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian cancer
errJOURNAL OF GERIATRIC ONCOLOGY
IF2.7
err2020-05-01
err14
errOAAI
errJorgensen, Trine Lembrecht; Herrstedt, Jorn
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Mark G. Kris
H 指数: 149 · 论文数: 1.4K
J
J. Jack Lee
H 指数: 146 · 论文数: 2.8K
I
Ignace Vergote
H 指数: 135 · 论文数: 1.9K
É
Éduardo Bruera
H 指数: 129 · 论文数: 1.9K
M
Michael Kjær
H 指数: 125 · 论文数: 1.0K
查看更多